[Reevaluation of current antimicrobials. Series 13: cefamandole sodium. Discussion].
D002435:Cefamandole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy
D002435:Cefamandole